Bicara Therapeutics Inc.’s BCAX share price has dipped by 14.66%, which has investors questioning if this is right time to buy.

Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Bicara Therapeutics in a report issued on Monday, March 31st. Cantor Fitzgerald analyst E. Schmidt now expects ...

Equities research analysts at Wedbush cut their Q1 2025 EPS estimates for Bicara Therapeutics in a note issued to investors on Thursday, March 27th. Wedbush analyst D. Nierengarten now expects that ...

Institute of Biology and Experimental Medicine, National Council for Scientific and Technical Research, Buenos Aires, Argentina. Research Center of Biomedical Biotechnology, Environmental and ...

B7-33, a synthetic analog of relaxin-2, has emerged as a focal point in contemporary scientific research due to its selective ...

Studies suggest that by acting as a decoy receptor for myostatin—a protein believed to inhibit muscular tissue development—ACE-031 may offer novel avenues for research into wasting disorders that ...

A new therapy that first made headlines in 2021 is now showing potential to heal human cartilage. Developed by scientists at ...

HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCCUpdated data from ongoing Phase 1/1b trial in 1L ...

A landmark review in Nature Reviews Genetics dissects the rare and common genetic variants that shape human height. The paper ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

Eggs are often hailed as a superfood for hair growth due to their richness in biotin, a B vitamin that plays a key role in the production of keratin, the protein that makes up hair. Biotin ...